RFA-AG-20-014: Geroscience Approaches to Alzheimer's Disease (R21 Clinical Trial Not Al... - 0 views
-
MiamiOH OARS on 14 Mar 19This Funding Opportunity Announcement (FOA) invites applications proposing research on the specific role of aging biology in the development, etiology and treatment of Alzheimer's disease. Aging is by far the main risk factor for most chronic diseases, a fact recognized by the field of geroscience. Recent advances in the fields of basic aging biology and geroscience now allow researchers to address mechanistically the role of aging in Alzheimer's disease. Applications that make use of geroscience principles and test the role of different hallmarks of aging biology are specifically appropriate, while those focused solely on aging biology, or solely on Alzheimer's disease will be deemed nonresponsive to the FOA.